Assay for gene deletion of GST-1 in human samples based on the polymerase chain reaction
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 30, 1993
Grant Date -
N/A
app pub date -
Apr 13, 1990
filing date -
Apr 13, 1990
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Methods for the detection of GST-1 gene deletion in human blood or tissue samples. The polymerase chain reaction is used to identify the presence or absence of the GST-1 gene in human clinical samples as a means of assessing susceptibility to neoplasia or toxicity upon chemical exposure. The method may also be used on human tumor samples to assess the possibility of resistance to certain chemotherapeutic agents.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully